DMRA
$24.01
Post-MarketAs of Mar 17, 8:00 PM UTC
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
Recent News
No recent news found.